Skip to main content
Eye logoLink to Eye
. 2020 Nov 16;35(9):2579–2584. doi: 10.1038/s41433-020-01273-4

The natural history of conjunctival naevi in children and adolescents

Guy S Negretti 1,, Kelsey A Roelofs 1, Bertil Damato 1, Mandeep Sagoo 1,2, Sahar Parvizi 3, Victoria M L Cohen 1,2
PMCID: PMC7668404  PMID: 33199866

Abstract

Objective

The objective of this study is to characterise the natural history of conjunctival naevi in a paediatric and adolescent population.

Methods

All children and adolescents referred to Moorfields Ocular Oncology Service for evaluation between January 2015 and 2020 were included. Exclusion criteria included age >20 years old and lack of anterior segment photographs. A total of 77 patients were included with a mean age of 12 years (standard deviation: 3.9; range, 4–20). The main outcome measures were: number of conjunctival naevi that grew, changed in pigmentation, required excisional biopsy, or were histologically malignant. If there was growth, the percentage increase in size was measured.

Results

At their first visit, 13% of patients (10/77) were discharged to local follow-up and 10% (8/77) proceeded to excisional biopsy, four further patients underwent excisional biopsy after a period of follow-up. On histopathological assessment, 92% (11/12) of lesions were benign conjunctival naevi. One patient, who had suspicious clinical features at presentation, had conjunctival melanoma. Fifty-nine patients were followed over a median of 1.1 years (interquartile range: 1.54; range, 3 months to 4 years). Eight per cent (5/59) of conjunctival naevi enlarged in diameter by a mean percentage increase in size of 2%, whereas 5% (3/59) showed increased pigmentation and 8.5% (5/59) showed decreased pigmentation.

Conclusions

Growth of conjunctival naevi in children is infrequent (8%) and the large majority of those excised are benign. Because of a lack of evidence, these patients are often followed for years in ophthalmic practice. This series demonstrates that prolonged follow-up may not be necessary.

Subject terms: Eye cancer, Eye cancer, Eye manifestations

Introduction

Conjunctival naevi account for 61% of tumours in children in a recent case series of tumours referred to a large ocular oncology service in the USA [1]. Clinically, compared to naevi, conjunctival melanomas are thicker, with larger basal diameters, lacking cysts and having prominent feeder vessels and intrinsic vasculature [1]. Pigmented lesions involving the cornea or located in palpebral conjunctiva, plica or caruncle also raise suspicion for conjunctival melanoma [2]. While there have been two previously published large case series reporting the natural history of conjunctival naevi, the mean age at presentation in both of these studies was >30 years [2, 3]. Both these studies demonstrated similar clinical findings. For example, most naevi were located in bulbar locations in horizontal meridians, either temporally or nasally. Both studies found growth of naevi in some patients (8 and 4%). This growth was, in general, not associated with malignancy, which was rare (0.7 and 0%) [2, 3]. Our impression, in clinical practice, not previously published, is that most conjunctival naevi appear and enlarge in the second half of the first decade of life.

To the best of our knowledge, there are no sizeable case series in the literature reporting the natural history of conjunctival naevi in children and adolescents. Because of this, a cautious approach is often adopted so that these patients tend to be followed for several years. As families often live far from the hospital, ongoing regular visits can be costly and disruptive to schooling. The purpose of this study was to describe the natural history of conjunctival naevi in children and adolescents, with the aim of improving evidence-based management with respect to biopsy, follow-up protocols and family counselling.

Methods

This is a single centre retrospective case series study. The electronic patient record was searched for the key term ‘conjunctival naevus’ to identify patients referred to the Moorfields Eye Hospital Ocular Oncology Service for evaluation between January 2015 and January 2020. Exclusion criteria included age >20 years at first visit even if the naevus had been noticed prior to their 20th birthday, and insufficient photographic documentation of the naevi to allow analysis. This meant that at least two sequential photographs were required for all subjects who underwent a period of observation rather than excision at their first visit. There was no specific minimum follow-up time.

Clinical notes were reviewed for demographic data, including age, sex and ethnicity, referring clinician details (i.e., optician, general practitioner and ophthalmologist), tumour laterality and past medical history. Lesion characteristics recorded included: iris colour; lesion location, size and colour; and the presence or absence of cysts, feeder vessels, intrinsic vessels and hair. For patients who were examined more than once, sequential colour photographs were examined by the authors (GSN and KAR) for (a) change in lesion size and/or (b) change in pigmentation. Where a change in size was noted, the change in area of the naevus was measured using the SketchAndCalc™ application to define the contour of the naevus to calculate the area of the lesion (see Fig. 1). If, on a particular visit, no photo was taken then we relied on the clinical notes to inform us of any change.

Fig. 1. Example of a conjunctival naevus that grew.

Fig. 1

At presentation (A) and 5 months later (B). The SketchAndCalc Application was used to measure the area before (C) and after (D) growth.

Anterior segment OCT was not routinely performed, so changes in thickness were estimated from the photographs.

Descriptive statistics were used to estimate mean ± standard deviation (SD) (range) when normally distributed, and median (interquartile range (IQR), range) when not. This study was approved by the Institutional Review Board at Moorfields Eye Hospital (CA20/ONC/607). The study adhered to the tenets of the Declaration of Helsinki.

Results

Between January 2015 and January 2020, 92 children/adolescents were referred to Moorfields Eye Hospital Ocular Oncology Service for evaluation of conjunctival naevi. Fifteen patients were excluded because of poor photographic documentation of the naevus, leaving a total of 77 cases. There were more males (47/77; 61%) than females (30/77; 39%) and left and right eyes were affected in approximately equal numbers (36/77; 47% and 41/77; 53%, respectively). The mean age at presentation was 12 years (SD: 3.9; range, 4–20). Approximately one-third of patients were white (24/77; 31%) (Table 1).

Table 1.

Patient demographics and a summary of the management of the naevi in this study.

Number (%)
Demographics
 Age at presentation mean ± SD, (range), years 12 ± 3.9, (4–19)
 Male 47 (61%)
 Female 30 (39%)
 Race
   White 24 (31%)
   Black 10 (13%)
   Asian 16 (21%)
   Mixed 1 (1%)
   Unknown 22 (29%)
   Other 4 (5%)
 Underlying systemic condition
   Wilms' tumour 1 (1.3%)
   Eczema 1 (1.3%)
   Anal stenosis/solitary kidney 1 (1.3%)
   Asperger’s syndrome 1 (1.3%)
   Ex premature (35 weeks) 1 (1.3%)
Management
 Observation 65 (84%)
 Excisional biopsy 12 (16%)
 Reason for excision
   Patient request 9 (75%)
   Suspicion of melanoma at presentation 1 (8.3%)
   Growth during observation period 1 (8.3%)
   Increased pigment during observation period 1 (8.3%)
 Histologic type
   Compound nevus 8 (66.6%)
   Junctional nevus 1 (8.3%)
   Combined nevus 1 (8.3%)
   Intraepithelial nevus 1 (8.3%)
   Melanoma 1 (8.3%)

Table 2 summarises the ocular and naevus findings of all patients at first presentation and those who were followed up at MEH. Most naevi were seen in brown-eyed individuals (60/77; 78%). Most (74/77; 96%) naevi were located in the bulbar conjunctiva. They tended to be either in the temporal (41/77; 53%) or nasal (32/77; 42%) quadrants. No naevi were found in the tarsal, forniceal or inferior bulbar conjunctiva. Cysts were frequently observed (63/77; 82%). Most naevi were brown (44/77; 57%). Feeder vessels were observed in 21/77 (27%) of patients. Intrinsic vessels were present in 24/77 (31%). Hair was observed in one caruncular naevus. In 57% of cases (44/77), the posterior border of the naevus involved the limbus, and in one case (1/77; 1.3%) the naevus involved the cornea.

Table 2.

Summary of ocular and naevus findings of all naevi at presentation and of those 59 cases followed up at MEH.

Ocular/nevus findings All nevi (%) Monitored nevi (%)
Left eye 36 (47%) 30 (51%)
Right eye 41 (53%) 29 (49%)
Iris colour
  Blue 9 (12%) 8 (14%)
  Green 6 (8%) 4 (7%)
  Brown 60 (78%) 45 (76%)
  Unknown 2 (2%) 2 (3%)
Naevus location
  Bulbar 74 (96%) 56 (95%)
  Caruncle 3 (4%) 3 (5%)
Quadrant
  Temporal 41 (53%) 30 (51%)
  Nasal 32 (42%) 26 (44%)
  Superior 4 (5%) 3 (5%)
  Inferior 0 0
Largest basal diameter, mean (range), mm 4.8 (1.0–10) 4.5 (1.0–7.8)
Colour
  Brown 44 (57%) 33 (56%)
  Tan 3 (4%) 3 (5%)
  Amelanotic 14 (18%) 11 (19%)
  Mixed 16 (21%) 12 (20%)
Cysts present 63 (82%) 49 (83%)
Feeder vessels present 21 (27%) 14 (24%)
Intrinsic vessels present 24 (31%) 18 (31%)
Hair present 1 (1%) 1 (1%)
Posterior margin touching limbus 44 (57%) 35 (59%)

At their first visit, eight children were listed for excisional biopsy: seven because of patient request and one because of features suspicious of malignancy at presentation (Fig. 2).

Fig. 2. Photograph of the naevus that presented with features suspicous of malignancy.

Fig. 2

These features were: largest basal diameter 9mm, corneal involvement, feeder vessels and recurrence at the site of a previously excised atypical naevus.

All the other children underwent a period of observation, 59 under the Ocular Oncology Service at Moorfields and 10 with their local general ophthalmologist. Data from the local ophthalmologists were not attained so these children were effectively lost to follow-up from this study. All the 59 children monitored at Moorfields maintained follow-up until they were discharged from the clinic or the study finished. Median follow-up for children at Moorfields was 1.1 years (IQR: 1.54; range, 3 months to 4 years). A summary of the patients’ management is shown in Table 1.

During this follow-up period at Moorfields (mean: 1.1 years), 5/59; 8.5% of naevi showed an increase in diameter. The average percentage increase in area was 20% (range, 2–60). 2/59; 3% of these naevi also had an associated increase in pigmentation and, conversely, 2/59; 3 showed a decrease in pigmentation. 3/59; another 5% children had no growth but increased pigmentation and 5/59; and 8.5% had no growth but decreased pigmentation. No naevi had an increase in thickness. In our series, conjunctival naevi tended to depigment in older children whereas documented growth tended to occur in younger children; however, these differences were not statistically significant (two sample t-tests, p = 0.9 and p = 0.23). Changes in pigment or size were not seen in association with topical drops (e.g., antihistamine or steroid).

We found progression, whether enlargement or change in colour, in 13/59 (22%) cases; however, during the follow-up period, only four children underwent excisional biopsy: Two due to patient request and two because of increased pigment or growth. Therefore, most of the documented change was only monitored clinically. All biopsies were performed using the ‘no touch’ technique. The histopathology of the 12 biopsied tumours revealed: 8 compound naevi, 1 junctional naevus, 1 combined naevus, 1 intraepithelial naevus and 1 melanoma.

The one case of conjunctival melanoma occurred in a 18-year old, white male (Fig. 2). As there was a high pre-operative suspicion of melanoma, double freeze thaw cryotherapy was applied at the time of surgery and the conjunctival defect was closed using an amniotic membrane graft. The diagnosis of melanoma was confirmed using four-colour FISH. The tumour thickness was 1 mm. Because the tumour involved the lateral and deep margins histologically but not clinically, this patient was treated with adjunctive strontium brachytherapy post biopsy and has been followed for 5 years with no evidence of tumour recurrence. The naevus that was biopsied because of growth was a compound naevus with some nuclear pleomorphism in the junctional component so the diagnosis of naevus was confirmed with four-colour FISH. The naevus biopsied due to increased pigmentation was a junctional naevus.

Discussion

There are many similarities between our results and those looking at conjunctival naevi predominantly in adults (Table 3) [2, 3].

Table 3.

A comparison of the results of our study with the two other large studies looking at the natural history of conjunctival naevi [2, 3].

Variable This study Shields et al. [2] Levecq et al. [3]
Age at presentation, mean (range), years 12 (4–19) 30 (2–93) 31 (1–90)
Male 47 (61%) 201 (49%) 140 (55%)
Female 30 (39%) 209 (51%) 115 (45%)
Race
  White 24 (31%) 365 (89%) 218 (85%)
  Black 10 (13%) 23 (6%) 32 (13.5%)
  Asian 16 (21%) 8 (2%) 3 (1%)
  Mixed 1 (1%) 0 0
  Unknown 22 (29%) 0 0
  Other 4 (5%) 14 (3%) 2 (<1%)
Naevus location
  Bulbar 74 (96%) 302 (72%) 170 (66.6%)
  Caruncle 3 (4%) 61 (15%) 56 (22%)
Quadrant
  Temporal 41 (53%) 190 (46%) 89 (36%)
  Nasal 32 (42%) 184 (44%) 129 (52%)
  Superior 4 (5%) 23 (6%) 21 (8%)
  Inferior 0 21 (5%) 9 (4%)
Largest basal diameter, mean (range), mm 4.8 (1.0–10) 4.1 (0.2–30.0) 4.3
Colour
  Brown 44 (57%) 271 (65%) 131 (51%)
  Tan 3 (4%) 80 (19%) 71 (28%)
  Amelanotic 14 (18%) 67 (16%) 53 (21%)
  Mixed 16 (21%) 0 0
Cysts present 63 (82%) 271 (65%) 146 (57%)
Feeder vessels present 21 (27%) 137 (33%) 69 (27%)
Intrinsic vessels present 24 (31%) 160 (38%) 54 (21%)
Hair present 1 (1%) Not reported Not reported
Anterior margin touching limbus 44 (57%) 202 (48%) 104 (41%)
Growth during observation period 5/59 (8.5%) 10/149 (7%) Not reported
Pigment change during observation period 8/59 (14%) 20/149 (13%) Not reported
Reason for excisional biopsy
  Patient request 9 (75%) 16 (10%) 62 (83%)
  Rule out malignancy 3 (25%) 144 (90%) 13 (17%)
Histologic type
  Compound nevus 8/12 (66.6%) 103/151 (68%) 55/75 (74%)
  Junctional nevus 1/12 (8.3%) 5/151 (3%) 4/75 (5%)
  Combined nevus 1/12 (8.3%) 6/151 (4%) 0
  Intraepithelial naevus 1/12 (8.3%) 0
  Other naevus 0 34/151 (23%) 16 (21%)
  Melanoma 1/12 (8.3%) 3/151 (2%) 0

Like the other studies, most naevi in our study were located on the bulbar conjunctiva (95%), were either in the temporal (53%) or nasal (42%) horizontal quadrants, with cysts (82%) and often involving the limbus (57%). All these features have been recognised previously as being more commonly seen in naevi than melanomas and thus are signs clinicians specifically look for when assessing likelihood of malignancy [2, 4]. The fact that most naevi in this study had these reassuring clinical signs is reflected in the benign histopathology and the lack of malignant transformation of the naevi. The one naevus that had worrisome clinical features at presentation (9 mm largest basal diameter, corneal involvement and recurrence at the site of a previously excised atypical naevus) proved to be histologically malignant.

It is interesting that in our study 31% of patients were white, whilst 34% were black or Asian. This compares to 89% white in the study by Shields et al. [2] and 85% in the study by Levecq et al. [3]. This reflects the multicultural population of London and the peri-London location of our referrers especially for paediatric and adolescent patients.

The histopathology from the excised naevi demonstrated a predominance of compound naevi, which is similar to previous studies [2, 3, 5, 6]. We did not note a significant percentage of junctional naevi in our study; this differs from previous reports, which have noted significant junctional activity in conjunctival naevi in children, as compared to adults [2, 5, 6]. It is difficult to infer too much from this finding given the small numbers of naevi excised in this study. In common with results previously reported by Levecq et al., the major reason for excising lesions in this study was patient request: 75% in this study and 83% in Levecq et al. [3]. This is in contrast to Shields et al. [2], who reported that only 10% of lesions were excised for cosmetic reasons (see Table 3). Patient or parent request was the main indication for surgery in our cohort; this is not surprising, especially as the mean age of the patients was 12 years and therefore the parents were involved in the consent process. In our experience, the opinions of the family especially related to cancer phobias are often greater than the concerns of the patient in this younger age group. As children become teenagers, the request for surgical excision is more often based on cosmetic concerns, which may arise out of peer pressure.

Growth of conjunctival naevi was uncommon in this study (8.5%). We found a similar incidence of growth to that reported by Shields et al. (8.5 versus 7%), whose study included paediatric cases; however, only one-third of our patients were Caucasian compared to almost 90% of those seen at the Wills Eye Hospital, suggesting that ethnicity of the patient is not related to growth of conjunctival naevi. It is important to exclude complexion-related melanosis when diagnosing conjunctival naevi. In only one child did growth of the naevus prompt excisional biopsy; histopathology showed the lesion to be a benign compound naevus. Naevus growth and change in pigmentation in childhood and adolescence have been recognised previously and, alone, are not considered to be signs of malignancy [2, 3]. This is the reason why only two out of 13 cases in our series that demonstrated a change in colour or size underwent surgical removal. Depigmentation is not a worrisome feature in conjunctival naevi, as reflected by the fact that all naevi that depigmented in this study showed cysts. It is possible that a change in the size or number of cysts leads the clinician to suspect that these naevi are depigmenting. It has been suggested that changes in the colour or size of conjunctival naevi might be due to inflammation in the naevus rather than malignant change. Zamir et al. [7] found that 75% of conjunctival naevi in children have some degree of inflammation and this tends to occur mostly in children with a history of allergic/vernal conjunctivitis.

Limitations of this study include the fact, although all children had photographs taken at multiple visits, some children did not have photographs taken at every visit, though clinical examination always compared against the previously taken photographs. We therefore had to rely on clinical notes documenting lack of growth in some cases where photographs were not available. Another limitation is the follow-up. At the time the patients in this study were seen, anterior segment OCT was not performed routinely in our practice. In future, it would be helpful to repeat this study using anterior segment OCT, which is being used more widely [8]. This imaging is likely to increase sensitivity with which changes in size, particularly thickness, are detected and is more reflective of how we are likely to be practicing ocular oncology in the future.

This study provides reassurance that clinical features may allow conjunctival naevi to be distinguished from melanomas in children and adolescents, as is the case in adults. In addition, some benign lesions show growth, which in children is not necessarily an indication of malignant transformation. At this time, during the COVID-19 pandemic, every attempt should be made to reduce the number of face-to-face consultations at tertiary referral centres. This study will hopefully give reassurance to clinicians that children with conjunctival naevi showing benign clinical features can safely be monitored in the community. Surgical removal is rarely required unless suspicious clinical features are present.

Summary

What was known before

  • The natural history of conjunctival naevi in adults has been characterised before.

  • Due to limited knowledge about the natural history of conjunctival naevi in children these are often followed up for long periods of time in tertiary referral centres.

What this study adds

  • We characterise the natural history of conjunctival naevi in children and adolescents.

  • We provide reassurance that prolonged follow-up may not be necessary.

Acknowledgments

Funding

The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Shields CL, Sioufi K, Alset AE. Clinical features differentiating benign from malignant conjunctival tumors in children. JAMA Ophthalmol. 2017;135:215–24. doi: 10.1001/jamaophthalmol.2016.5544. [DOI] [PubMed] [Google Scholar]
  • 2.Shields CL, Fasiuddin AF, Mashayekhi A, Shields JA. Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch Ophthalmol. 2004;122:167–75. doi: 10.1001/archopht.122.2.167. [DOI] [PubMed] [Google Scholar]
  • 3.Levecq L, De Potter P, Jamart J. Conjunctival nevi clinical features and therapeutic outcomes. Ophthalmology. 2010;117:35–40. doi: 10.1016/j.ophtha.2009.06.018. [DOI] [PubMed] [Google Scholar]
  • 4.Shields CL, Shields JA, Gündüz K, Cater J, Mercado GV, Gross N, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis and death in 150 consecutive patients. Arch Ophthalmol. 2000;118:1497–507. doi: 10.1001/archopht.118.11.1497. [DOI] [PubMed] [Google Scholar]
  • 5.McDonnell JM, Carpenter JD, Jacobs P, Wan WL, Gilmore JE. Conjunctival melanocytic lesions in children. Ophthalmology. 1989;96:986–93. doi: 10.1016/S0161-6420(89)32772-2. [DOI] [PubMed] [Google Scholar]
  • 6.Gerner N, Nørregaard JC, Jensen OA, Prause JU. Conjunctival naevi in Denmark 1960-1980. A 21-year follow-up study. Acta Ophthalmol Scand. 1996;74:334–7. doi: 10.1111/j.1600-0420.1996.tb00703.x. [DOI] [PubMed] [Google Scholar]
  • 7.Zamir E, Mechoulam H, Micera A, Levi-Schaffer F, Pe’er J. Inflamed juvenile con-junctival nevus: clinicopathological characterization. Br J Ophthalmol. 2002;86:28–30. doi: 10.1136/bjo.86.1.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Shields CL, Belinsky I, Romanelli-Gobbi M, Guzman J, Jr Mazzuca D, Green WR, et al. Anterior segment optical coherence tomography of conjunctival nevus. Ophthalmology. 2011;118:915–9. doi: 10.1016/j.ophtha.2010.09.016. [DOI] [PubMed] [Google Scholar]

Articles from Eye are provided here courtesy of Nature Publishing Group

RESOURCES